Search Tag: Chief Business Officer
2024 25 Jan
Diana Hausman, M.D., Accomplished Oncologist and Drug Developer, Appointed Chief Medical Officer Kyle Rasbach, Ph.D., Pharm.D., Experienced Biotechnology Portfolio Manager, Appointed Chief Business Officer Zentalis ® Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small...Read more
2023 05 Apr
BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS) leveraging the Biorchestra Drug Delivery System (BDDSTM), which combines targeted cell delivery capabilities and proprietary RNA chemistries to develop first-in-class therapeutics announced the appointment of Mr....Read more
2022 10 Nov
Mardi C. Dier joins as Chief Financial Officer and Chief Business Officer Mina Kim joins as Chief Legal and Administrative Officer CFO Gil Labrucherie departs the company for personal family reasons ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology announced...Read more
2022 17 Oct
Experienced and Innovative Business Development Professional to Join Leadership Team to Capitalize on Breadth of aiSPIRE Platform Value Creation Opportunities ImmuneID, a biopharmaceutical company that leverages existing antibody responses to rapidly unveil the complexities of the immune system, thereby revealing pathways leading to precise,...Read more
2022 06 Sep
LenioBio GmbH, the German life science biotech offering a disruptive protein manufacturing technology announced the appointment of Mr. Jasper Levink to its Leadership Team in the role of Chief Business Officer. In his new role as Chief Business Officer, Mr. Levink will be responsible for driving LenioBio’s business development and business strategy. ...Read more
2022 18 Aug
Veteran biotech and pharmaceutical executive will help company increase its growth and international impact Standigm Inc. , the leading workflow artificial intelligence (AI) drug discovery company announced the appointment of Chief Business Officer Carl Foster . Based in our U.S. office, Foster will be responsible for expanding strategic...Read more
2022 16 Jun
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases announced the appointment of Dr Hemanshu Shah as Chief Business Officer (CBO), based in the US. ValoTx’s CEO, Paul Higham, said, “I am delighted to welcome Dr Hemanshu Shah as our CBO. Hemanshu brings a wealth of business development...Read more